VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types-A Meta-Analysis.

Jordan W ConwayJorja BradenSerigne N LoRichard A ScolyerMatteo S CarlinoAlexander M MenziesGeorgina V LongInes Pires da Silva

Published in: Cancers (2023)

The addition of vascular endothelial growth factor inhibitors to standard management improved survival outcomes in patients with liver metastasis across cancers.

Keyphrases

vascular endothelial growth factor
liver metastases
endothelial cells
papillary thyroid
squamous cell
squamous cell carcinoma
young adults